COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 175 filers reported holding COHERUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $157,738 | +24.1% | 42,176 | +41.7% | 0.00% | – |
Q2 2023 | $127,071 | -62.7% | 29,759 | -40.2% | 0.00% | – |
Q1 2023 | $340,283 | -87.0% | 49,749 | -84.9% | 0.00% | -100.0% |
Q4 2022 | $2,613,450 | -59.9% | 329,981 | -51.3% | 0.00% | -50.0% |
Q3 2022 | $6,516,000 | +32.3% | 678,103 | -0.4% | 0.00% | +33.3% |
Q2 2022 | $4,927,000 | -8.2% | 680,633 | +63.7% | 0.00% | 0.0% |
Q1 2022 | $5,368,000 | -20.0% | 415,815 | -1.1% | 0.00% | 0.0% |
Q4 2021 | $6,708,000 | -39.1% | 420,346 | -38.7% | 0.00% | -40.0% |
Q3 2021 | $11,016,000 | -4.6% | 685,478 | -17.9% | 0.01% | -16.7% |
Q2 2021 | $11,542,000 | +2.9% | 834,589 | +8.7% | 0.01% | 0.0% |
Q1 2021 | $11,218,000 | +7.6% | 767,853 | +28.0% | 0.01% | 0.0% |
Q4 2020 | $10,424,000 | -6.1% | 599,809 | -0.9% | 0.01% | -25.0% |
Q3 2020 | $11,099,000 | -17.4% | 605,219 | -19.6% | 0.01% | -20.0% |
Q2 2020 | $13,442,000 | +60.8% | 752,682 | +46.1% | 0.01% | +42.9% |
Q1 2020 | $8,358,000 | -8.1% | 515,323 | +2.0% | 0.01% | +16.7% |
Q4 2019 | $9,092,000 | +125.9% | 505,117 | +154.0% | 0.01% | +100.0% |
Q3 2019 | $4,025,000 | -10.1% | 198,826 | -1.8% | 0.00% | 0.0% |
Q2 2019 | $4,475,000 | -67.2% | 202,558 | -79.7% | 0.00% | -62.5% |
Q1 2019 | $13,638,000 | -36.7% | 999,972 | -58.0% | 0.01% | -46.7% |
Q4 2018 | $21,559,000 | -65.2% | 2,382,438 | -36.5% | 0.02% | -16.7% |
Q3 2018 | $61,900,000 | +69.7% | 3,751,578 | +44.0% | 0.02% | +80.0% |
Q2 2018 | $36,484,000 | +382.9% | 2,606,099 | +281.1% | 0.01% | +150.0% |
Q1 2018 | $7,555,000 | +140.1% | 683,821 | +91.0% | 0.00% | +100.0% |
Q4 2017 | $3,147,000 | +194.7% | 357,954 | +346.5% | 0.00% | +100.0% |
Q3 2017 | $1,068,000 | -8.7% | 80,166 | -1.8% | 0.00% | 0.0% |
Q2 2017 | $1,170,000 | -18.2% | 81,613 | +20.4% | 0.00% | 0.0% |
Q1 2017 | $1,431,000 | -49.5% | 67,811 | -32.6% | 0.00% | -50.0% |
Q4 2016 | $2,831,000 | -48.9% | 100,679 | -51.4% | 0.00% | -50.0% |
Q3 2016 | $5,540,000 | +603.0% | 206,989 | +342.4% | 0.00% | +300.0% |
Q2 2016 | $788,000 | +415.0% | 46,792 | +542.7% | 0.00% | – |
Q1 2016 | $153,000 | +14.2% | 7,280 | +24.2% | 0.00% | – |
Q4 2015 | $134,000 | -71.5% | 5,861 | -75.1% | 0.00% | – |
Q3 2015 | $471,000 | -33.8% | 23,516 | -4.6% | 0.00% | – |
Q2 2015 | $711,000 | – | 24,662 | +246520.0% | 0.00% | – |
Q1 2015 | $0 | -100.0% | 10 | -99.8% | 0.00% | – |
Q4 2014 | $103,000 | – | 6,335 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 2,868,221 | $39,123,000 | 3.77% |
Rubric Capital Management LP | 2,640,771 | $36,020,000 | 3.36% |
Ghost Tree Capital, LLC | 450,000 | $6,138,000 | 1.60% |
Hound Partners | 1,959,318 | $26,725,000 | 1.15% |
Sivik Global Healthcare LLC | 225,000 | $3,069,000 | 1.13% |
Pier Capital, LLC | 525,848 | $7,173,000 | 1.11% |
Rhenman & Partners Asset Management AB | 451,131 | $6,153,000 | 0.72% |
Kohlberg Kravis Roberts & Co. L.P. | 3,055,055 | $41,671,000 | 0.63% |
Temasek Holdings (Private) Ltd | 6,556,116 | $89,425,000 | 0.62% |
Atika Capital Management LLC | 188,000 | $2,564,000 | 0.52% |